Acute-phase proteins and other systemic responses to inflammation.

A large number of changes, distant from the site or sites of inflammation and involving many organ systems, may accompany inflammation. In 1930 interest was focused on these changes by the discovery of C-reactive protein (so named because it reacted with the pneumococcal C-polysaccharide) in the plasma of patients during the acute phase of pneumococcal pneumonia.1 Accordingly, these systemic changes have since been referred to as the acute-phase response,2 even though they accompany both acute and chronic inflammatory disorders. New acute-phase phenomena continue to be recognized, and the mechanisms mediating them are becoming better understood. This review summarizes much of . . .

[1]  W. Dijk,et al.  Interleukin‐6‐Type Cytokine‐induced Changes in Acute Phase Protein Glycosylationa a , 1995, Annals of the New York Academy of Sciences.

[2]  P. Limburg,et al.  C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. , 1990, The Journal of rheumatology.

[3]  T. Yue,et al.  Interferon-inducible Protein-10 Involves Vascular Smooth Muscle Cell Migration, Proliferation, and Inflammatory Response* , 1996, The Journal of Biological Chemistry.

[4]  L. Moldawer,et al.  Proinflammatory cytokines, nutritional support, and the cachexia syndrome , 1997, Cancer.

[5]  M. Brand,et al.  Proinflammatory cytokines interleukin 1β and tumor necrosis factor α inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells , 1996 .

[6]  Guy Hoffman,et al.  Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. , 1993, The Journal of clinical investigation.

[7]  F. D. de Beer,et al.  Human serum amyloid A (SAA) protein: a prominent acute‐phase reactant for clinical practice , 1996, European journal of clinical investigation.

[8]  L. Mccawley,et al.  Alpha-1-antichymotrypsin inhibits the NADPH oxidase-enzyme complex in phorbol ester-stimulated neutrophil membranes. , 1992, Journal of immunology.

[9]  A. Shaw,et al.  Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. , 1995, Immunity.

[10]  L. Leon,et al.  The adaptive value of fever. , 1996, Infectious disease clinics of North America.

[11]  P. Edwards,et al.  Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. , 1995, Circulation.

[12]  M. Jordana,et al.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. , 1998, The Journal of clinical investigation.

[13]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[14]  J. Roth,et al.  Fever suppression by subdiaphragmatic vagotomy in guinea pigs depends on the route of pyrogen administration. , 1997, The American journal of physiology.

[15]  M. Hentze,et al.  Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. , 1997, Journal of immunology.

[16]  Thomas Francis,et al.  SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS , 1930, The Journal of experimental medicine.

[17]  R. Dwek,et al.  Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. , 1990, Gut.

[18]  J. Gauldie,et al.  Murine cardiotrophin-1 stimulates the acute-phase response in rat hepatocytes and H35 hepatoma cells. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[19]  G. Lozanski,et al.  Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. , 1992, Cytokine.

[20]  I. Kushner,et al.  Kinetic modeling and mathematical analysis indicate that acute phase gene expression in Hep 3B cells is regulated by both transcriptional and posttranscriptional mechanisms. , 1995, The Journal of clinical investigation.

[21]  L. Curtiss,et al.  Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. , 1995, Journal of lipid research.

[22]  H. Kawaguchi,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Transcriptional Induction of Cyclooxygenase-2 in Osteoblasts Is Involved in Interleukin-6-Induced , 2022 .

[23]  G. Vercellotti,et al.  C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor , 1993 .

[24]  T. Spector,et al.  Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. , 1997, Arthritis and rheumatism.

[25]  K. Feingold,et al.  Effects of endotoxin and cytokines on lipid metabolism. , 1994, Current opinion in lipidology.

[26]  P. Heinrich,et al.  Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. , 1992, Journal of immunology.

[27]  L. Kanz,et al.  In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates [see comments] , 1992 .

[28]  T. Speroff,et al.  Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. , 1991, Journal of immunology.

[29]  D. Xia,et al.  Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis. , 1996, American journal of respiratory and critical care medicine.

[30]  C. Dinarello Interleukin-1 and the pathogenesis of the acute-phase response. , 1984, The New England journal of medicine.

[31]  R. Bone,et al.  Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. , 1996, Critical care medicine.

[32]  R. Means Pathogenesis of the anemia of chronic disease: A cytokine‐mediated anemia , 1995, Stem cells.

[33]  T. Vischer,et al.  Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. , 1997, The Journal of rheumatology.

[34]  H. Munro,et al.  Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1. , 1990, The Journal of biological chemistry.

[35]  M. V. van Leeuwen,et al.  Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. , 1994, The Journal of rheumatology.

[36]  G. Lozanski,et al.  Identification of a C-reactive Protein Binding Site in Two Hepatic Carboxylesterases Capable of Retaining C-reactive Protein within the Endoplasmic Reticulum* , 1996, The Journal of Biological Chemistry.

[37]  I. Kushner Regulation of the Acute Phase Response by Cytokines , 2015, Perspectives in biology and medicine.

[38]  H. Meltzer,et al.  Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs , 1997, Psychiatry Research.

[39]  D. Xia,et al.  Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H. Colten,et al.  Molecular Biology of the Acute Phase Plasma Proteins , 1987 .

[41]  G. Chrousos,et al.  The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.

[42]  J. Filep,et al.  Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. , 1997, The Journal of clinical investigation.

[43]  J. Banchereau,et al.  Interleukin 4 inhibits the production of some acute‐phase proteins by human hepatocytes in primary culture , 1993, FEBS letters.

[44]  I. Kushner,et al.  SERUM C‐REACTIVE PROTEIN LEVELS IN DISEASE * , 1982, Annals of the New York Academy of Sciences.

[45]  H. Moutsopoulos,et al.  High C-reactive protein response in lupus polyarthritis. , 1983, Clinical and experimental rheumatology.

[46]  J. Gauldie,et al.  Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. , 1987, Journal of immunology.

[47]  P. Sehgal,et al.  High levels of "complexed" interleukin-6 in human blood. , 1992, The Journal of biological chemistry.

[48]  Dennis J. Rivet,et al.  Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory Anorexia , 1997, The Journal of experimental medicine.

[49]  C. Gabay,et al.  Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. , 1997, The Journal of clinical investigation.

[50]  S. Thompson,et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.

[51]  W. van Dijk,et al.  Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera , 1993, The Journal of experimental medicine.

[52]  G. Fantuzzi,et al.  Defective inflammatory response in interleukin 6-deficient mice , 1994, The Journal of experimental medicine.

[53]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[54]  H. Baumann,et al.  Insulin cooperates with IL-1 in regulating expression of alpha 1-acid glycoprotein gene in rat hepatoma cells. , 1994, Cytokine.

[55]  T. Vischer,et al.  Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response. , 1994, Arthritis and rheumatism.

[56]  M. Feldmann,et al.  Role of cytokines in rheumatoid arthritis. , 1996, Annual review of immunology.

[57]  C. Dinarello Cytokines as endogenous pyrogens. , 1999, The Journal of infectious diseases.

[58]  I. Kushner Semantics, inflammation, cytokines and common sense. , 1998, Cytokine & growth factor reviews.

[59]  G. Ciliberto,et al.  Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. , 1997, The Journal of clinical investigation.

[60]  P. Lansdorp,et al.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[61]  S. Dower,et al.  Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. , 1994, Journal of immunology.